HU191512B - Process for production of dosed through the nose medical preparatives containing ergot-alcaloids - Google Patents
Process for production of dosed through the nose medical preparatives containing ergot-alcaloids Download PDFInfo
- Publication number
- HU191512B HU191512B HU83323A HU32383A HU191512B HU 191512 B HU191512 B HU 191512B HU 83323 A HU83323 A HU 83323A HU 32383 A HU32383 A HU 32383A HU 191512 B HU191512 B HU 191512B
- Authority
- HU
- Hungary
- Prior art keywords
- hydrogen
- formula
- nasal
- dihydroergotamine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8202781 | 1982-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
HU191512B true HU191512B (en) | 1987-02-27 |
Family
ID=10528017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU83323A HU191512B (en) | 1982-02-01 | 1983-01-31 | Process for production of dosed through the nose medical preparatives containing ergot-alcaloids |
Country Status (27)
Country | Link |
---|---|
JP (1) | JPS58134017A (de) |
AT (1) | AT385656B (de) |
AU (1) | AU565613B2 (de) |
BE (1) | BE895750A (de) |
CA (1) | CA1197783A (de) |
CH (1) | CH653555A5 (de) |
DE (1) | DE3302949A1 (de) |
DK (1) | DK164771C (de) |
ES (1) | ES8502865A1 (de) |
FI (1) | FI81258C (de) |
FR (1) | FR2539994B1 (de) |
GR (1) | GR81320B (de) |
HK (1) | HK59989A (de) |
HU (1) | HU191512B (de) |
IE (1) | IE54532B1 (de) |
IL (1) | IL67822A (de) |
IT (1) | IT1197558B (de) |
KE (1) | KE3888A (de) |
LU (1) | LU84613A1 (de) |
MY (1) | MY8700766A (de) |
NL (1) | NL192325C (de) |
NZ (1) | NZ203117A (de) |
PH (1) | PH22198A (de) |
PT (1) | PT76166B (de) |
SE (1) | SE454402B (de) |
SG (1) | SG34389G (de) |
ZA (1) | ZA83673B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
GB0910375D0 (en) * | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
EP3735244B1 (de) * | 2018-01-05 | 2022-11-23 | Impel Pharmaceuticals Inc. | Intranasale verabreichung von dihydroergotamin durch eine olfaktorische präzisionsvorrichtung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
GB1202885A (en) * | 1966-12-22 | 1970-08-19 | Sandoz Ltd | Pharmaceutical compositions comprising alkaloids |
DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
FR2387035A1 (fr) * | 1977-04-12 | 1978-11-10 | Cassenne Lab Sa | Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux |
DE2831728C2 (de) * | 1978-07-19 | 1982-12-23 | Krewel-Werke Gmbh, 5208 Eitorf | Arzneimittel zur Behandlung von Kopfschmerzen |
-
1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 CA CA000420539A patent/CA1197783A/en not_active Expired
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
-
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
-
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5169849A (en) | Nasal pharmaceutical compositions | |
US11717571B2 (en) | Intranasal epinephrine formulations and methods for the treatment of disease | |
ES2626134T3 (es) | Composiciones de bepotastina | |
AU714303B2 (en) | Formulation for intranasal administration | |
EP0999841B1 (de) | Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen | |
HU199678B (en) | Process for producing aerosols containing nitroglicerol | |
US20040171666A1 (en) | Therapeutic compositions for intranasal administration which include KETOROLAC | |
NZ263891A (en) | Pharmaceutical composition of progesterone and/or 17-beta-estradiol, the active ingredient(s) being dissolved in an oil that is the inner phase of an oil-water two-phase system | |
US6193954B1 (en) | Formulations for pulmonary delivery of dopamine agonists | |
RU2373925C2 (ru) | Назальные фармацевтические композиции и способы их применения | |
CZ20032752A3 (cs) | Přípravky pro nasální aplikaci, obsahující imidazotriazinon | |
US4885305A (en) | Nasal compositions | |
US20080176913A1 (en) | Transdermal compositions of pramipexole having enhanced permeation properties | |
HU191512B (en) | Process for production of dosed through the nose medical preparatives containing ergot-alcaloids | |
GB2114001A (en) | Nasal pharmaceutical compositions | |
AU2021254650B2 (en) | Intranasal epinephrine formulations and methods for the treatment of disease | |
WO2006093786A2 (en) | Scopolamine sublingual spray | |
KR100384346B1 (ko) | 엘레트립탄 헤미술페이트 및 카페인을 포함하는 약제학적조성물 | |
WO2021044357A1 (en) | Apomorphine formulation | |
HU211543A9 (hu) | Hajtógáz nélküli nitroglicerin aeroszol helyi alkalmazás céljára Az átmeneti oltalom az 1-5. igénypontokra vonatkozik. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HU90 | Patent valid on 900628 | ||
HPC4 | Succession in title of patentee |
Owner name: NOVARTIS AG, CH |